Vivo Bio Tech signs supply contract with Biological E

Vivo Bio Tech signs supply contract with Biological E
The value of the contract is estimated to be in the range of Rs 20 crore to Rs 30 crore per year, for each of the next three years, Vivo Bio Tech said in a regulatory filing. Image Credit: ANI
  • Country:
  • India

Leading contract research firm Vivo Bio Tech on Saturday said it has signed a long-term supply contract with vaccine maker Biological E.

The value of the contract is estimated to be in the range of Rs 20 crore to Rs 30 crore per year, for each of the next three years, Vivo Bio Tech said in a regulatory filing.

Hyderabad-based Vivo Bio-Tech is a full-service CRO (contract research organisation) offering drug development and discovery services to pharmaceutical and biotech companies worldwide.

TRENDING

OPINION / BLOG / INTERVIEW

Tech-savvy preschool teachers more willing to bring GenAI into classrooms

Machine learning brings speed to pharma’s slowest pipeline

AI-Powered Smart-City-Brain Could Transform Future Urban Sustainability Models

Human Friendships Beat AI Chatbots in Reducing Loneliness, Study Reveals

DevShots

Latest News

Connect us on

LinkedIn Quora Youtube RSS
Give Feedback